{
"@context": "https://schema.org",
"@graph": [
{
"@type": "WebPage",
"@id": "https://www.fortrea.com/insights/electronic-medication-diary-delivers-high-compliance-rates-rare-cancer-study#webpage",
"url": "https://www.fortrea.com/insights/electronic-medication-diary-delivers-high-compliance-rates-rare-cancer-study",
"name": "Electronic medication diary delivers high compliance rates in a rare cancer study",
"description": "This Fortrea case study highlights how an electronic medication diary in clinical trials improved patient compliance, data accuracy, and overall study performance in a rare cancer study. The use of digital diary tools enabled real-time data capture, reduced missed entries, and provided better visibility into patient adherence compared to traditional methods. By addressing common challenges in patient-reported data collection, the approach supported more consistent data capture, minimized protocol deviations, and enhanced monitoring throughout the study lifecycle. This case study demonstrates how electronic medication diaries can strengthen compliance, improve data quality, and support more efficient execution in oncology and rare disease clinical trials."
},
{
"@type": "BreadcrumbList",
"itemListElement": [
{
"@type": "ListItem",
"position": 1,
"name": "Home",
"item": "https://www.fortrea.com"
},
{
"@type": "ListItem",
"position": 2,
"name": "Insights",
"item": "https://www.fortrea.com/insights/"
},
{
"@type": "ListItem",
"position": 3,
"name": "Electronic medication diary delivers high compliance rates in a rare cancer study",
"item": "https://www.fortrea.com/insights/electronic-medication-diary-delivers-high-compliance-rates-rare-cancer-study"
}
]
},
{
"@type": "Organization",
"@id": "https://www.fortrea.com/#organization",
"name": "Fortrea",
"url": "https://www.fortrea.com",
"description": "Fortrea is a global contract research organization built on more than 30 years of experience and one of the earliest CRO legacies in the industry—as Covance, evolving within Labcorp, and now operating as Fortrea. With deep expertise across Phase I–IV clinical trials, Fortrea advances clinical research through a patient-centric approach that prioritizes meaningful outcomes, stronger site–CRO relationships, and operational excellence. Fortrea partners with biopharmaceutical, biotech, and medical device companies to advance therapies through every stage of clinical development. This commitment is further reinforced by the launch of Fortrea Intelligent Technology, enabling smarter, more connected, and data-driven clinical development. Through Fortrea Intelligent Technology, the organization is advancing data-driven, technology-enabled clinical development to improve speed, quality, and patient outcomes. It is shaped by experience, innovation, and a commitment to raising standards in clinical research—focused on accelerating development and helping bring life-changing treatments to patients around the world.",
"logo": "https://www.fortrea.com/sites/default/files/2025-05/fortrea-logo-without-background.png",
"sameAs": [
"https://www.linkedin.com/company/fortrea",
"https://www.threads.net/@fortreacro",
"https://twitter.com/fortrea",
"https://www.youtube.com/@Fortrea/",
"https://www.facebook.com/Fortrea-104143099267108",
"https://www.instagram.com/fortreacro"
]
},
{
"@type": "Article",
"@id": "https://www.fortrea.com/insights/electronic-medication-diary-delivers-high-compliance-rates-rare-cancer-study#casestudy",
"mainEntityOfPage": {
"@id": "https://www.fortrea.com/insights/electronic-medication-diary-delivers-high-compliance-rates-rare-cancer-study#webpage"
},
"headline": "Electronic Medication Diary in Clinical Trials Improves Patient Compliance | Fortrea Case Study",
"description": "This Fortrea case study highlights how an electronic medication diary in clinical trials improved patient compliance, data accuracy, and overall study performance in a rare cancer study. The use of digital diary tools enabled real-time data capture, reduced missed entries, and provided better visibility into patient adherence compared to traditional methods. By addressing common challenges in patient-reported data collection, the approach supported more consistent data capture, minimized protocol deviations, and enhanced monitoring throughout the study lifecycle. This case study demonstrates how electronic medication diaries can strengthen compliance, improve data quality, and support more efficient execution in oncology and rare disease clinical trials.",
"genre": "Case Study",
"image": {
"@type": "ImageObject",
"url": "https://www.fortrea.com/sites/default/files/2025-04/GettyImages-464723137.jpg"
},
"author": {
"@type": "Organization",
"name": "Fortrea",
"url": "https://www.fortrea.com/"
},
"publisher": {
"@id": "https://www.fortrea.com/#organization"
},
"datePublished": "2025-04-29",
"dateModified": "2025-04-29",
"encoding": {
"@type": "MediaObject",
"contentUrl": "https://www.fortrea.com/sites/default/files/2025-04/CS_0100_DCT%20Medication%20Diary_0425_HighRes.pdf",
"encodingFormat": "application/pdf"
}
}
]
}